Status:
ACTIVE_NOT_RECRUITING
Investigating the Direct Superior Approach for Total Hip Arthroplasty as an Effective Alternative to Traditional Posterior Approach
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Total Hip Arthroplasty
Eligibility:
All Genders
18-81 years
Phase:
NA
Brief Summary
Hip replacement surgery is an effective option for treating pain and functional impairment in chronic hip conditions. Various surgical approaches have been developed to expose the hip joint for the pr...
Detailed Description
The primary objective of this study is to compare the health status and functional outcomes of patients who have undergone total hip arthroplasty (THA) utilizing the direct superior (DS) approach to t...
Eligibility Criteria
Inclusion
- Symptomatic osteoarthritis of the hip indicating surgical intervention
- Uncemented femoral stem and acetabular cup indicated
- Patients between the ages of 18 and 80, inclusive.
- Ability to give informed consent
Exclusion
- Patients less than 18 years of age, or 81 years of age and older
- Active or prior infection of the affected hip
- Morbid obesity (BMI \> 45)
- Medical condition precluding major surgery
- Severe osteoporosis or osteopenia
- Neuromuscular impairment
- Patients with known or tested-positive allergy to metals
- Pregnancy
Key Trial Info
Start Date :
July 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2025
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT03227549
Start Date
July 10 2018
End Date
December 1 2025
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Capital District Health Authority
Halifax, Nova Scotia, Canada, B3H 3A7